Paris-based pharma Sanofi-Aventis has pushed back its offer deadline for Massachusetts-based biotech Genzyme by six weeks. All other terms, including the $69 per share bid, remain unchanged. So far, very few shareholders have responded.
Continue reading Sanofi-Aventis Extends Its Tender Offer for Genzyme
Sanofi-Aventis Extends Its Tender Offer for Genzyme originally appeared on DailyFinance on Mon, 13 Dec 2010 09:50:00.
Filed Under: Company News, Investing, Health Care, Genzyme Corporation , Sanofi Aventis, Stocks in the News